Please use this identifier to cite or link to this item:
Title: Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents
Authors: Ruffles, Tom
Jones, Christina J.
Palmer, Colin
Turner, Steve
Grigg, Jonathan
Tavendale, Roger
Hogarth, Fiona
Rauchhaus, Petra
Pilvinyte, Kristina
Hannah, Romanie
Smith, Helen Elizabeth
Littleford, Roberta
Lipworth, Brian
Mukhopadhyay, Somnath
Keywords: Science::Medicine
Issue Date: 2021
Source: Ruffles, T., Jones, C. J., Palmer, C., Turner, S., Grigg, J., Tavendale, R., Hogarth, F., Rauchhaus, P., Pilvinyte, K., Hannah, R., Smith, H. E., Littleford, R., Lipworth, B. & Mukhopadhyay, S. (2021). Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents. European Respiratory Journal, 58(2), 2004107-.
Journal: European Respiratory Journal
Abstract: The A allele of rs1042713 (Arg16 amino acid) in the β2-adrenoreceptor is associated with poor response to long-acting β2-agonist (LABA) in young people with asthma. Our aim was to assess whether the prescribing of second-line controller with LABA or a leukotriene receptor antagonist according to Arg16Gly genotype would result in improvements in Pediatric Asthma-Related Quality of Life Questionnaire (PAQLQ).
ISSN: 0903-1936
DOI: 10.1183/13993003.04107-2020
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
Rights: © 2021 The authors. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:LKCMedicine Journal Articles

Citations 20

Updated on Sep 30, 2023

Web of ScienceTM
Citations 20

Updated on Sep 28, 2023

Page view(s)

Updated on Oct 3, 2023

Google ScholarTM




Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.